5876 - 5900 of 6422 Results
Title
Year
- Allogeneic Bone Marrow‐Derived Mesenchymal Stem Cells for Parkinson's Disease: A Randomized Trial2025OPENTitle: Allogeneic Bone Marrow‐Derived Mesenchymal Stem Cells for Parkinson's Disease: A Randomized TrialJournal Name: Movement DisordersPublisher: WileyVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.70028Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.70028Citation Count: 0
-
OPENTitle: Neuron-autonomous susceptibility to induced synuclein aggregation is exacerbated by endogenous Lrrk2 mutations and ameliorated by Lrrk2 genetic knock-outJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 2Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcz052Best OA location URL: https://academic.oup.com/braincomms/article-pdf/2/1/fcz052/33640016/fcz052.pdfCitation Count: 28
-
OPENTitle: α‐synuclein genetic variability: A biomarker for dementia in Parkinson diseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 79Issue #: 6Start Page: 991End Page: 999Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.24664Best OA location URL: http://hdl.handle.net/2027.42/137619Citation Count: 93
-
OPENTitle: Therapeutic potential of autophagy-enhancing agents in Parkinson’s diseaseJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page: 11End Page: 11Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-017-0154-3Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-017-0154-3Citation Count: 266
-
OPENTitle: Immortalized Parkinson's disease lymphocytes have enhanced mitochondrial respiratory activityJournal Name: Disease Models & MechanismsPublisher: The Company of BiologistsVol: 9Issue #: 11Start Page: 1295End Page: 1305Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1242/dmm.025684Best OA location URL: http://dmm.biologists.org/content/dmm/9/11/1295.full.pdfCitation Count: 61
-
OPENTitle: CHCHD2 mutant mice link mitochondrial deficits to PD pathophysiologyJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 11Issue #: 46Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/sciadv.adu0726Best OA location URL: https://doi.org/10.1126/sciadv.adu0726Citation Count: 0
-
OPENTitle: Neuromelanin‐MRI to Quantify and Track Nigral Depigmentation in Parkinson's Disease: A Multicenter Longitudinal Study Using Template‐Based Standardized AnalysisJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 5Start Page: 1028End Page: 1039Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28934Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28934Citation Count: 25
-
OPENTitle: Development and validation of an expanded antibody toolset that captures alpha-synuclein pathological diversity in Lewy body diseasesJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-023-00604-yBest OA location URL: https://www.nature.com/articles/s41531-023-00604-y.pdfCitation Count: 38
-
OPENTitle: Full sequencing and haplotype analysis of MAPT in Parkinson's disease and rapid eye movement sleep behavior disorderJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 6Start Page: 1016End Page: 1020Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27385Best OA location URL: http://hdl.handle.net/11380/1205920Citation Count: 37
-
OPENTitle: Nortriptyline inhibits aggregation and neurotoxicity of alpha-synuclein by enhancing reconfiguration of the monomeric formJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 106Issue #:Start Page: 191End Page: 204Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2017.07.007Best OA location URL: https://doaj.org/article/416c1a4af85442e1a86a6af150c46583Citation Count: 33
-
OPENTitle: Discovery of Volatile Biomarkers of Parkinson’s Disease from SebumJournal Name: ACS Central SciencePublisher: American Chemical Society (ACS)Vol: 5Issue #: 4Start Page: 599End Page: 606Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/acscentsci.8b00879Best OA location URL: https://doi.org/10.1021/acscentsci.8b00879Citation Count: 146
-
OPENTitle: Antemortem detection of Parkinson’s disease pathology in peripheral biopsies using artificial intelligenceJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page: 21End Page: 21Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-022-01318-7Best OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-022-01318-7Citation Count: 16
-
OPENTitle: Validating Differential Volatilome Profiles in Parkinson’s DiseaseJournal Name: ACS Central SciencePublisher: American Chemical Society (ACS)Vol: 7Issue #: 2Start Page: 300End Page: 306Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/acscentsci.0c01028Best OA location URL: https://doi.org/10.1021/acscentsci.0c01028Citation Count: 36
-
OPENTitle: Optical Structural Analysis of Individual α‐Synuclein OligomersJournal Name: Angewandte Chemie International EditionPublisher: WileyVol: 57Issue #: 18Start Page: 4886End Page: 4890Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/anie.201710779Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/anie.201710779Citation Count: 42
-
OPENTitle: High Cerebrospinal DOPA Decarboxylase Level Predicts Cognitive Decline in Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mdc3.70367Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.70367Citation Count: 0
-
OPENTitle: Orthogonal analysis of mitochondrial function in Parkinson’s disease patientsJournal Name: Cell Death & DiseasePublisher: Springer Science and Business Media LLCVol: 15Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41419-024-06617-6Best OA location URL: https://www.nature.com/articles/s41419-024-06617-6.pdfCitation Count: 8
-
OPENTitle: Loss of Sarm1 does not suppress motor neuron degeneration in the SOD1G93A mouse model of amyotrophic lateral sclerosisJournal Name: Human Molecular GeneticsPublisher: Oxford University Press (OUP)Vol: 27Issue #: 21Start Page: 3761End Page: 3771Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1093/hmg/ddy260Best OA location URL: https://academic.oup.com/hmg/article-pdf/27/21/3761/26127115/ddy260.pdfCitation Count: 53
-
OPENTitle: Neonatal mitochondrial abnormalities due to PINK1 deficiency: Proteomics reveals early changes relevant to Parkinson׳s diseaseJournal Name: Data in BriefPublisher: Elsevier BVVol: 6Issue #:Start Page: 428End Page: 432Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.dib.2015.11.070Best OA location URL: https://doi.org/10.1016/j.dib.2015.11.070Citation Count: 8
-
OPENTitle: Wrinkle in the plan: miR-34a-5p impacts chemokine signaling by modulating CXCL10/CXCL11/CXCR3-axis in CD4+, CD8+ T cells, and M1 macrophagesJournal Name: Journal for ImmunoTherapy of CancerPublisher: BMJVol: 8Issue #: 2Start Page: e001617End Page: e001617Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1136/jitc-2020-001617Best OA location URL: https://jitc.bmj.com/content/jitc/8/2/e001617.full.pdfCitation Count: 44
-
OPENTitle: Reversible Conformational Conversion of α-Synuclein into Toxic Assemblies by GlucosylceramideJournal Name: NeuronPublisher: Elsevier BVVol: 97Issue #: 1Start Page: 92End Page: 107.e10Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuron.2017.12.012Best OA location URL: http://www.cell.com/article/S0896627317311352/pdfCitation Count: 195
-
OPENTitle: C9orf72-G4C2 Intermediate Repeats and Parkinson’s Disease; A Data-Driven HypothesisJournal Name: GenesPublisher: MDPI AGVol: 12Issue #: 8Start Page: 1210End Page: 1210Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/genes12081210Best OA location URL: https://www.mdpi.com/2073-4425/12/8/1210/pdf?version=1628215581Citation Count: 3
-
OPENTitle: More of less: Novel multi-ome profiling of single human neuronsJournal Name: Cell GenomicsPublisher: Elsevier BVVol: 2Issue #: 3Start Page: 100110End Page: 100110Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.xgen.2022.100110Best OA location URL: https://doi.org/10.1016/j.xgen.2022.100110Citation Count: 0
-
OPENTitle: Changes in α-Synuclein Posttranslational Modifications in an AAV-Based Mouse Model of Parkinson’s DiseaseJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 24Issue #: 17Start Page: 13435End Page: 13435Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms241713435Best OA location URL: https://www.mdpi.com/1422-0067/24/17/13435/pdf?version=1693464631Citation Count: 4
-
OPENTitle: S-Nitrosylation of PINK1 Attenuates PINK1/Parkin-Dependent Mitophagy in hiPSC-Based Parkinson’s Disease ModelsJournal Name: Cell ReportsPublisher: Elsevier BVVol: 21Issue #: 8Start Page: 2171End Page: 2182Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.celrep.2017.10.068Best OA location URL: http://www.cell.com/article/S2211124717315310/pdfCitation Count: 113
-
OPENTitle: Neuroprotection of low dose carbon monoxide in Parkinson’s disease models commensurate with the reduced risk of Parkinson’s among smokersJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s41531-024-00763-6Best OA location URL: https://www.nature.com/articles/s41531-024-00763-6.pdfCitation Count: 12